Price$7.13+1.02 (+16.78%)
2026-03-052026-06-08
News · 26 weeks64+64%
2025-12-142026-06-07
Mix5090d
- Insider24(48%)
- SEC Filings12(24%)
- Other9(18%)
- Offering4(8%)
- Earnings1(2%)
Latest news
25 items- SECSenseonics Holdings Inc. filed SEC Form 8-K: Other Events8-K - Senseonics Holdings, Inc. (0001616543) (Filer)
- PRReal-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop SystemsEversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM's differentiated approach and high performance New data expands on findings shared at ATTD and reinforces Eversense 365's strong patient adherence, glucometrics and hypoglycemic outcomes across an entire year GERMANTOWN, Md., June 06, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today announces further data from a large real-world evidence study which reveals
- SECSEC Form SD filed by Senseonics Holdings Inc.SD - Senseonics Holdings, Inc. (0001616543) (Filer)
- PRSenseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026GERMANTOWN, Md., June 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ:SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today highlights two key company events during the 86th Scientific Sessions of the American Diabetes Association (ADA), taking place June 5-8 in New Orleans, Louisiana. Senseonics will be hosting an analyst event to discuss the Eversense 365 platform, as well as an oral presentation on the ADA program discussing real world evidence of the world's first and only one year CGM system. Analyst Event DetailsSenseonics
- INSIDERChief Medical Officer Kaufman Francine was granted 63,177 shares, increasing direct ownership by 54% to 181,067 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERGC & Corp. Development Advisor Horton Kenneth L was granted 157,943 shares, increasing direct ownership by 115% to 295,057 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERChief Operating Officer Jain Mukul was granted 270,759 shares, increasing direct ownership by 110% to 517,057 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Fiorentino Edward was granted 9,852 shares, increasing direct ownership by 13% to 83,339 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Defalco Stephen P was granted 9,852 shares, increasing direct ownership by 10% to 111,019 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Roeder Douglas A was granted 9,852 shares, increasing direct ownership by 7% to 154,487 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Prince Douglas S was granted 9,852 shares, increasing direct ownership by 17% to 67,816 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Larkin Sharon was granted 9,852 shares, increasing direct ownership by 31% to 41,862 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Steven Edelman was granted 9,852 shares, increasing direct ownership by 12% to 88,681 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERPresident and CEO Goodnow Timothy T was granted 553,701 shares, increasing direct ownership by 89% to 1,176,346 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERChief Financial Officer Sullivan Frederick T. was granted 90,253 shares, increasing direct ownership by 64% to 231,874 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERChief Commercial Officer Hansen Brian B was granted 90,253 shares, increasing direct ownership by 214% to 132,357 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- SECSEC Form S-8 filed by Senseonics Holdings Inc.S-8 - Senseonics Holdings, Inc. (0001616543) (Filer)
- SECSenseonics Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Senseonics Holdings, Inc. (0001616543) (Filer)
- INSIDERChief Medical Officer Kaufman Francine covered exercise/tax liability with 6,058 shares, decreasing direct ownership by 5% to 117,890 units (SEC Form 4) to satisfy withholding tax4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERChief Financial Officer Sullivan Frederick T. covered exercise/tax liability with 9,005 shares, decreasing direct ownership by 6% to 141,621 units (SEC Form 4) to satisfy tax liability4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERChief Operating Officer Jain Mukul covered exercise/tax liability with 13,681 shares, decreasing direct ownership by 5% to 246,298 units (SEC Form 4) (for tax liability)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERPresident and CEO Goodnow Timothy T covered exercise/tax liability with 28,598 shares, decreasing direct ownership by 4% to 622,645 units (SEC Form 4) to cover withholding tax4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERGC & Corp. Development Advisor Horton Kenneth L covered exercise/tax liability with 7,320 shares, decreasing direct ownership by 5% to 137,114 units (SEC Form 4) (for tax liability)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- INSIDERDirector Roeder Douglas A bought $126,134 worth of shares (22,686 units at $5.56), increasing direct ownership by 19% to 144,635 units (SEC Form 4)4 - Senseonics Holdings, Inc. (0001616543) (Issuer)
- SECSEC Form 10-Q filed by Senseonics Holdings Inc.10-Q - Senseonics Holdings, Inc. (0001616543) (Filer)
SENS FAQ
6 questionsWhat does Senseonics Holdings Inc. do?
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days. It serves healthcare providers and patients through...Where does SENS stock trade?
Senseonics Holdings Inc. (SENS) is listed on AMEX.What sector and industry is SENS in?
Senseonics Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about SENS?
Senseonics Holdings Inc. has had 7 recent analyst actions on file. The most recent action was from Stifel: Hold with a $900.00 price target on 2025-10-21.What companies are similar to SENS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SENS side-by-side with any of them on Quantisnow.How can I track SENS on Quantisnow?
Quantisnow aggregates Senseonics Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SENS to receive live email and push alerts on every new disclosure.